460 related articles for article (PubMed ID: 31859138)
21. Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary Disease.
Bansilal S; Bonaca MP; Cornel JH; Storey RF; Bhatt DL; Steg PG; Im K; Murphy SA; Angiolillo DJ; Kiss RG; Parkhomenko AN; Lopez-Sendon J; Isaza D; Goudev A; Kontny F; Held P; Jensen EC; Braunwald E; Sabatine MS; Oude Ophuis AJ
J Am Coll Cardiol; 2018 Feb; 71(5):489-496. PubMed ID: 29406853
[TBL] [Abstract][Full Text] [Related]
22. 1-Year Outcomes of Patients Undergoing Primary Angioplasty for Myocardial Infarction Treated With Prasugrel Versus Ticagrelor.
Motovska Z; Hlinomaz O; Kala P; Hromadka M; Knot J; Varvarovsky I; Dusek J; Jarkovsky J; Miklik R; Rokyta R; Tousek F; Kramarikova P; Svoboda M; Majtan B; Simek S; Branny M; Mrozek J; Cervinka P; Ostransky J; Widimsky P;
J Am Coll Cardiol; 2018 Jan; 71(4):371-381. PubMed ID: 29154813
[TBL] [Abstract][Full Text] [Related]
23. Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry.
D'Ascenzo F; Bertaina M; Fioravanti F; Bongiovanni F; Raposeiras-Roubin S; Abu-Assi E; Kinnaird T; Ariza-Solé A; Manzano-Fernández S; Templin C; Velicki L; Xanthopoulou I; Cerrato E; Rognoni A; Boccuzzi G; Omedè P; Montabone A; Taha S; Durante A; Gili S; Magnani G; Autelli M; Grosso A; Blanco PF; Garay A; Quadri G; Varbella F; Queija BC; Paz RC; Fernández MC; Pousa IM; Gallo D; Morbiducci U; Dominguez-Rodriguez A; Valdés M; Cequier A; Alexopoulos D; Iñiguez-Romo A; Gaita F; Rinaldi M; Lüscher TF
Eur J Prev Cardiol; 2020 May; 27(7):696-705. PubMed ID: 30862233
[TBL] [Abstract][Full Text] [Related]
24. Safety and Efficacy of Triple Therapy With Ticagrelor or Prasugrel Versus Clopidogrel After Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.
Gill K; Servati N; Flahive J; Fraielli K
J Cardiovasc Pharmacol Ther; 2021 Nov; 26(6):625-629. PubMed ID: 34236915
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular and Bleeding Risks in Acute Myocardial Infarction Newly Treated With Ticagrelor vs. Clopidogrel in Taiwan.
Lee CH; Cheng CL; Kao Yang YH; Chao TH; Chen JY; Li YH
Circ J; 2018 Feb; 82(3):747-756. PubMed ID: 29081474
[TBL] [Abstract][Full Text] [Related]
26. Ticagrelor Versus Clopidogrel in Patients with Late or Very Late Stent Thrombosis.
Zhou J; Tan Y; Liu C; Zhou P; Sheng Z; Li J; Chen R; Zhao H; Song L; Yan H
Cardiovasc Drugs Ther; 2020 Oct; 34(5):677-684. PubMed ID: 32572652
[TBL] [Abstract][Full Text] [Related]
27. Effects of Ticagrelor versus Clopidogrel in Patients with Coronary Bifurcation Lesions Undergoing Percutaneous Coronary Intervention.
Zheng W; Li Y; Tian J; Li L; Xie L; Mao Q; Tong W; Zhou D; Azzalini L; Zhao X
Biomed Res Int; 2019; 2019():3170957. PubMed ID: 31016189
[TBL] [Abstract][Full Text] [Related]
28. Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
You SC; Rho Y; Bikdeli B; Kim J; Siapos A; Weaver J; Londhe A; Cho J; Park J; Schuemie M; Suchard MA; Madigan D; Hripcsak G; Gupta A; Reich CG; Ryan PB; Park RW; Krumholz HM
JAMA; 2020 Oct; 324(16):1640-1650. PubMed ID: 33107944
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and Safety of Ticagrelor in Comparison to Clopidogrel in Elderly Patients With ST-Segment-Elevation Myocardial Infarctions.
Schmucker J; Fach A; Mata Marin LA; Retzlaff T; Osteresch R; Kollhorst B; Hambrecht R; Pohlabeln H; Wienbergen H
J Am Heart Assoc; 2019 Sep; 8(18):e012530. PubMed ID: 31538856
[TBL] [Abstract][Full Text] [Related]
30. Association of potent P2Y12 blockers with ischemic and bleeding outcomes in non-ST-segment elevation myocardial infarction.
Sim DS; Jeong MH; Kim HS; Gwon HC; Seung KB; Rha SW; Chae SC; Kim CJ; Cha KS; Park JS; Yoon JH; Chae JK; Joo SJ; Choi DJ; Hur SH; Seong IW; Cho MC; Kim DI; Oh SK; Ahn TH; Hwang JY;
J Cardiol; 2019 Feb; 73(2):142-150. PubMed ID: 30509351
[TBL] [Abstract][Full Text] [Related]
31. Comparison of prasugrel versus clopidogrel in Korean patients with acute myocardial infarction undergoing successful revascularization.
Park KH; Jeong MH; Kim HK; Ahn TH; Seung KB; Oh DJ; Choi DJ; Kim HS; Gwon HC; Seong IW; Hwang KK; Chae SC; Kim KB; Kim YJ; Cha KS; Oh SK; Chae JK;
J Cardiol; 2018 Jan; 71(1):36-43. PubMed ID: 28673508
[TBL] [Abstract][Full Text] [Related]
32. Risk of Major Bleeding With Potent Antiplatelet Agents After an Acute Coronary Event: A Comparison of Ticagrelor and Clopidogrel in 5116 Consecutive Patients in Clinical Practice.
Mullen L; Meah MN; Elamin A; Aggarwal S; Shahzad A; Shaw M; Hasara J; Rashid M; Fisher M; Ali T; Patel B; Ding WY; Grainger R; Heseltine T; Kirmani BH; Obeidat M; Kasolo Y; Thatchil J; Khand A
J Am Heart Assoc; 2021 Apr; 10(8):e019467. PubMed ID: 33834845
[TBL] [Abstract][Full Text] [Related]
33. One-year clinical outcomes of ticagrelor compared with clopidogrel after percutaneous coronary intervention in patients with acute myocardial infarction: From Korean Health Insurance Review and Assessment Data.
Kim C; Shin DH; Hong SJ; Ahn CM; Kim JS; Kim BK; Ko YG; Choi D; Hong MK; Park J; Lee H; Kim DS; Oh SK; Jang Y
J Cardiol; 2019 Mar; 73(3):191-197. PubMed ID: 30770037
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS Registries.
Peyracchia M; Saglietto A; Biolè C; Raposeiras-Roubin S; Abu-Assi E; Kinnaird T; Ariza-Solé A; Liebetrau C; Manzano-Fernández S; Boccuzzi G; Henriques JPS; Wilton SB; Velicki L; Xanthopoulou I; Correia L; Rognoni A; Fabrizio U; Nuñez-Gil I; Montabone A; Taha S; Fujii T; Durante A; Gili S; Magnani G; Autelli M; Grosso A; Kawaji T; Blanco PF; Garay A; Quadri G; Queija BC; Huczek Z; Paz RC; González-Juanatey JR; Fernández MC; Nie SP; D'Amico M; Pousa IM; Kawashiri MA; Gallo D; Morbiducci U; Dominguez-Rodriguez A; Lopez-Cuenca A; Cequier A; Alexopoulos D; Iñiguez-Romo A; Grossomarra W; Usmiani T; Rinaldi M; D'Ascenzo F
Am J Cardiovasc Drugs; 2020 Jun; 20(3):259-269. PubMed ID: 31586336
[TBL] [Abstract][Full Text] [Related]
35. Contemporary Use of Ticagrelor vs Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A GRACE Risk Score Stratification-Based Analysis in a Large-Scale, Real-World Study From China.
Qiu M; Na K; Qi Z; Zhou H; Li P; Xu K; Wang B; Liu H; Li J; Li Y; Han Y
Mayo Clin Proc; 2023 Jul; 98(7):1021-1032. PubMed ID: 37419570
[TBL] [Abstract][Full Text] [Related]
36. Net clinical benefit of different strategies of dual antiplatelet therapy in elderly patients: Data from the praise registry.
D'Ascenzo F; Elia E; de Filippo O; Manai R; Breviario S; Bruno F; Iannaccone M; Wańha W; Bianco M; Patti G; Raposeiras-Roubin S; Abu-Assi E; Bo M; De Ferrari GM; Conrotto F;
Int J Cardiol; 2022 Apr; 353():9-14. PubMed ID: 35090983
[TBL] [Abstract][Full Text] [Related]
37. Safety and Efficacy in Prasugrel- Versus Ticagrelor-Treated Patients With ST-Elevation Myocardial Infarction.
Dimitroulis D; Golabkesh M; Naguib D; Knoop B; Dannenberg L; Helten C; Pöhl M; Jung C; Kelm M; Zeus T; Polzin A
J Cardiovasc Pharmacol; 2018 Oct; 72(4):186-190. PubMed ID: 29985284
[TBL] [Abstract][Full Text] [Related]
38. Clopidogrel versus ticagrelor in East Asian patients aged 75 years or older with acute coronary syndrome: observations from the GF-APT registry.
Xi Z; Qiu Z; Li J; Qiu H; Guo T; Wang Y; Zheng J; Gao Y; Gao R
Platelets; 2022 Nov; 33(8):1270-1278. PubMed ID: 36050819
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Clinical Outcomes Between Ticagrelor and Prasugrel in Patients With ST-Segment Elevation Myocardial Infarction - Results From the Korea Acute Myocardial Infarction Registry-National Institutes of Health.
Kim MC; Jeong MH; Sim DS; Hong YJ; Kim JH; Ahn Y; Ahn TH; Seung KB; Choi DJ; Kim HS; Gwon HC; Seong IW; Hwang KK; Chae SC; Hur SH; Cha KS; Oh SK; Chae JK;
Circ J; 2018 Jun; 82(7):1866-1873. PubMed ID: 29643279
[TBL] [Abstract][Full Text] [Related]
40. Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial.
Gimbel M; Qaderdan K; Willemsen L; Hermanides R; Bergmeijer T; de Vrey E; Heestermans T; Tjon Joe Gin M; Waalewijn R; Hofma S; den Hartog F; Jukema W; von Birgelen C; Voskuil M; Kelder J; Deneer V; Ten Berg J
Lancet; 2020 Apr; 395(10233):1374-1381. PubMed ID: 32334703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
